COVID-19 and Cancer: Assessing the Impact of Disruptions to Care
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Category: AACR
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today The nationwide shutdown of elective clinical procedures implemented in...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
It is an exciting era for drug development in oncology. The many discoveries of new molecular targets, coupled with...
As we move slowly toward longer days and warmer temperatures, we bring you the latest round of highlighted articles...
Tuesday, March 8, marked International Women’s Day, a global celebration of the social, economic, cultural, and political achievements of...
This year, the American Association for Cancer Research (AACR) will celebrate its 115th birthday. From the very beginning, women...
For most solid tumors, traditional biopsies are the gold standard for diagnosing cancer and assessing molecular characteristics that may...
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
Putting off a routine medical examination for a few months might seem, to many, as routine as the examination...
Editor’s note: This story, written by Anna Azvolinsky, first appeared in Leading Discoveries, a magazine and website that raises...